ArticleInfection2024

Anti-spike antibody level is associated with the risk of clinical progression among subjects hospitalized with COVID-19 pneumonia: results from a retrospective cohort study.

Giuseppe Lapadula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.